Carcinoma, Islet Cell - 21 Studies Found Terminated : A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors : Carcinoma, Islet Cell Carcinoma, Pancreas : 2007-01-29 : Drug: sunitinib malate Recruiting : Antitumor Efficacy of Peptide Receptor Radionuclide Therapy With 177Lutetium -Octreotate Randomized vs Sunitinib in Unresectable Progressive Well-differentiated Neuroendocrine Pancreatic Tumor: First Randomized Phase II : Pancreatic Neuroendocrine Carcinoma : 2014-08-27 : Drug: Sunitinib Drug: 177Lu-DOTA0-Tyr3-Oct Completed : RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma : Neuroendocrine Carcinoma Islet Cell Carcinoma : 2005-06-07 : Drug: RAD001 Starting dose of Completed : A Study of IMC-A12 in Islet Cell Cancer : Carcinoma Neuroendocrine Tumors : 2008-10-27 : Biological: IMC-A12 (cixutumumab) Active, not recruiting : Ziv-Aflibercept in Treating and Computed Tomography Perfusion Imaging in Predicting Response in Patients With Pancreatic Neuroendocrine Tumors That Are Metastatic or Cannot Be Removed by Surgery : Multiple Endocrine Neoplasia Type 1 Pancreatic Neuroendocrine Carcinom : 2014-03-28 : Radiation: Computed Tomography Perfusion Imaging Recruiting : Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery : Pancreatic Neuroendocrine Tumor G1 Pancreatic Neuroendocrine Tumor G2 Pancreatic Alpha Cell Carcinoma Pancreatic Beta Islet Cell Carcinoma : 2011-10-04 : Drug: temozolomide Given PO Completed : Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy : Islet Cell Carcinoma Neuroendocrine Carcinoma Drug: Everolimus 10 mg Partici Withdrawn : Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy : Merkel Cell Carcinoma Islet Cell Carcinoma Drug: antineoplaston A10 Drug: antineoplas Recruiting : FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas : Gastro-enteropancreatic Neuroendocrine Tumor Pancreatic Cancer Drug: FOLFIRINOX The FOLFIRINO Next >>>
